Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Short term Debt (2020 - 2021)

Historic Short term Debt for Burning Rock Biotech (BNR) over the last 3 years, with Q2 2025 value amounting to $28000.0.

  • Burning Rock Biotech's Short term Debt changed N/A to $28000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $28000.0, marking a year-over-year change of. This contributed to the annual value of $372000.0 for FY2021, which is 9300.36% down from last year.
  • As of Q2 2025, Burning Rock Biotech's Short term Debt stood at $28000.0.
  • Burning Rock Biotech's Short term Debt's 5-year high stood at $5.0 million during Q1 2021, with a 5-year trough of $28000.0 in Q2 2025.